2jnp: Difference between revisions

New page: left|200px<br /><applet load="2jnp" size="350" color="white" frame="true" align="right" spinBox="true" caption="2jnp" /> '''Solution structure of matrix metalloproteina...
 
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
We structurally characterized the adducts of the catalytic domain of, matrix metalloproteinase-3 (MMP3) with three different nonpeptidic, inhibitors by solving the solution structure of one adduct, [MMP3-N-isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid] and, then by calculating structural models of the other two adducts using a, reduced set of experimental NMR data, following a recently proposed, procedure (Bertini et al. in J. Med. Chem. 48:7544-7559, 2005). The, inhibitors were selected with the criteria of maintaining in all of them, the same zinc-coordinating moiety and of selectively changing the, substituents and/or the functional groups. The backbone dynamics on, various time scales have been characterized as well. The comparison among, these structures and with others previously reported allowed us to, elucidate fine details of inhibitor-receptor interactions and to develop, some criteria, which could guide in optimizing the design of selective, inhibitors.
We structurally characterized the adducts of the catalytic domain of matrix metalloproteinase-3 (MMP3) with three different nonpeptidic inhibitors by solving the solution structure of one adduct [MMP3-N-isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid] and then by calculating structural models of the other two adducts using a reduced set of experimental NMR data, following a recently proposed procedure (Bertini et al. in J. Med. Chem. 48:7544-7559, 2005). The inhibitors were selected with the criteria of maintaining in all of them the same zinc-coordinating moiety and of selectively changing the substituents and/or the functional groups. The backbone dynamics on various time scales have been characterized as well. The comparison among these structures and with others previously reported allowed us to elucidate fine details of inhibitor-receptor interactions and to develop some criteria, which could guide in optimizing the design of selective inhibitors.


==About this Structure==
==About this Structure==
Line 14: Line 14:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Stromelysin 1]]
[[Category: Stromelysin 1]]
[[Category: Alcaraz, L.A.]]
[[Category: Alcaraz, L A.]]
[[Category: Banci, L.]]
[[Category: Banci, L.]]
[[Category: Bertini, I.]]
[[Category: Bertini, I.]]
Line 28: Line 28:
[[Category: nmr]]
[[Category: nmr]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 23 11:42:26 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 18:04:25 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA